Diabetic nephropathy--what are the unmet needs?

Area of Science:

• Nephrology
• Endocrinology
• Cardiology
• Public Health

Background:

• Diabetes and obesity pandemics are rising globally, particularly impacting Asian populations.
• Asian patients face elevated risks for diabetic kidney disease (DKD) due to genetic factors, obesity, and low-grade infections.
• DKD exacerbates metabolic issues like oxidative stress, anemia, and vascular calcification, significantly increasing cardiovascular disease (CVD) risk.

Purpose of the Study:

• To highlight the escalating burden of cardio-renal complications in Asian patients with diabetes and obesity.
• To identify key contributing factors and residual risks in DKD management.
• To suggest potential avenues for novel therapeutic strategies.

Main Methods:

• Review and synthesis of existing epidemiological data and clinical trial findings related to diabetes, obesity, and DKD in Asian populations.
• Analysis of the interplay between metabolic derangements, inflammation, and cardiovascular risk factors in DKD.
• Identification of unmet needs in current treatment paradigms.

Main Results:

• Asia is projected to experience the highest increase in diabetes and obesity, especially among younger demographics.
• Diabetic kidney disease in Asians is associated with a complex interplay of factors leading to increased oxidative stress, anemia, and vascular calcification.
• Even with optimal management of blood pressure, metabolic factors, and renin-angiotensin system inhibition, a significant residual risk for cardio-renal complications persists.

Conclusions:

• Urgent development of novel strategies is required to address the growing global epidemic of cardio-renal complications in diabetic and obese populations.
• Targeting obesity, low-grade inflammation, and anemia presents promising opportunities for intervention.
• Further research and clinical trials are essential to validate new therapeutic approaches for this high-risk group.